Please try another search
Arctic Bioscience AS is a Norway-based biotech company developing and commercializing both pharmaceutical and nutraceutical products based on the properties of herring roe oil. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The Company is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The Company's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.
Name | Age | Since | Title |
---|---|---|---|
Harald Nordal | 64 | 2015 | Co-Founder & Chairman |
Asbjorn Solevagseide | 62 | 2019 | Board Member |
Tore Andreas Froysa Tonseth | 42 | 2021 | Board Member |
Marita Holstad | - | - | Director |
Per Magne Eggesbo | 59 | 2015 | Board Member |
Hu Cao | - | 2021 | Board Member |
Jan Endre Vartdal | 51 | 2015 | Board Member |
Jostein Christian Dalland | 53 | 2020 | Independent Board Member |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review